A Phase 3, 56-Week, Randomised, Double-Blind, Placebo-Controlled Study (OA-11) Utilising Patient-Reported and Radiographic Outcomes Evaluating the Efficacy and Safety of a Lorecivivint Injection in Patients with Moderate to Severe Knee Osteoarthritis.
Clinical and experimental rheumatology（2025）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要